About the Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS)
Welcome to the Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) — a peer-reviewed, open-access platform dedicated to advancing cancer research, clinical oncology, and innovative treatments. We are committed to fostering global collaboration, sharing breakthrough discoveries, and improving cancer care through ethical, transparent, and high-quality publishing.
“We are passionate about scholarly publishing and committed to helping researchers share their work with the world. As your trusted publishing partner, we ensure a seamless, transparent, and supportive process from submission to publication.”
🎯Aims & Scope – Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS)
The Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) is dedicated to publishing high-quality, peer-reviewed research that advances cancer science, clinical practice, and global oncology care. Our mission is to provide a trusted platform where researchers, clinicians, and healthcare professionals share discoveries that shape the future of cancer prevention, diagnosis, treatment, and survivorship.
MJOCS welcomes original research articles, systematic reviews, clinical trials, case reports, and expert commentary across the full oncology spectrum, including:
- Solid Tumors & Hematologic Malignancies
- Cancer Genomics & Precision Oncology
- Immuno-oncology & Targeted Therapies
- Radiation & Surgical Oncology
- Chemotherapy & Drug Resistance
- Early Detection, Biomarkers & Diagnostic Advances
- Cancer Epidemiology & Population Health
- Survivorship, Palliative & Supportive Care
- Global Cancer Burden & Access to Care
- Pediatric, Geriatric & Rare Cancers
- AI, Imaging & Computational Oncology
By fostering open access, MJOCS ensures that vital oncology research is freely available worldwide—accelerating scientific progress, reducing health disparities, and promoting innovation in cancer care.
🔬 Science That Heals. Research That Matters.
Cancer is one of the world’s most complex health challenges — and tackling it requires knowledge that spans every corner of oncology. The Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) unites molecular biologists, immunologists, oncologists, radiation specialists, surgeons, and palliative care providers to publish peer-reviewed cancer research that drives innovation, informs clinical practice, and improves patient outcomes.
At MJOCS, we believe that research must not only advance science but also deliver real impact in cancer prevention, early detection, diagnosis, treatment, and survivorship care.
🌟 What Makes MJOCS Unique?
- Multidisciplinary Approach – Bridging basic science, translational research, and clinical oncology from bench to bedside.
- Focus on Innovation – Covering both established standards and emerging therapies such as precision oncology, immunotherapy, and AI in cancer care.
- Commitment to Equity – Highlighting research that addresses disparities and promotes global access to cancer treatment.
- Platform for All Evidence – Publishing groundbreaking discoveries alongside real-world data to inform better healthcare decisions.
By combining diversity of expertise with a commitment to open access, MJOCS ensures that every discovery contributes to a healthier, cancer-free future.
🏆 Editorial Excellence at MJOCS
The Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) features a distinguished international editorial board of leading scientists, oncologists, and clinical researchers committed to publishing rigorous, impactful, and transformative cancer research.
Our editorial priorities include:
✅ Cross-disciplinary collaboration bridging basic science, clinical oncology, and public health
✅ Transparency and integrity in peer review and editorial decisions
✅ Constructive mentorship for authors to strengthen scientific quality
✅ Global inclusivity, encouraging research from low- and middle-income countries
We welcome studies on:
- Novel oncology discoveries and therapeutic innovations
- Negative, neutral, or confirmatory results
- Clinical trials, pilot studies, and case-based insights
- Challenges in global cancer care, access, and health equity
MJOCS is dedicated to advancing oncology knowledge worldwide by supporting high-quality research that improves patient outcomes, informs policy, and fosters scientific collaboration.
🌟 Our Mission – Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS)
At the Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS), our mission is to empower the global oncology community by publishing timely, high-quality, and openly accessible cancer research. We are dedicated to advancing clinical practice, fostering innovation, and supporting worldwide initiatives to reduce the growing burden of cancer.
Through our open access platform, MJOCS strives to:
- Promote scientific excellence and uphold the highest standards of research transparency.
- Elevate underrepresented voices while addressing global oncology and healthcare disparities.
- Facilitate collaboration between researchers, clinicians, and policymakers for impactful progress.
- Translate laboratory discoveries into meaningful clinical applications that improve patient care and survival outcomes.
By bridging science, practice, and policy, MJOCS ensures that groundbreaking oncology research contributes to better cancer prevention, diagnosis, treatment, and survivorship across the world.
📖 Open Access & Publishing Ethics
The Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) is a fully open access journal, publishing under the Creative Commons Attribution License (CC BY 4.0). This means every article is free to read, share, and reuse worldwide, provided proper citation is given — ensuring that vital oncology knowledge is accessible without barriers.
At MJOCS, we are deeply committed to ethical publishing practices. We strictly follow the standards set by:
- COPE (Committee on Publication Ethics)
- ICMJE (International Committee of Medical Journal Editors)
- The Declaration of Helsinki for research involving human subjects
By upholding integrity, transparency, and accountability, MJOCS guarantees that published research in oncology and cancer studies meets the highest standards of scientific excellence and ethical responsibility.
🌐 Indexing & Global Reach
The Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) is actively pursuing indexing in leading databases including PubMed Central, Scopus, DOAJ, and Google Scholar. Our goal is to maximize the visibility, discoverability, and global impact of every published article.
By expanding our reach across these respected platforms, MJOCS ensures that your oncology research is accessible to clinicians, researchers, and policymakers worldwide, driving greater recognition, readership, and citations.
🌍 Join the Global Oncology Conversation
The Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) invites researchers, clinicians, advocates, and early-career oncology scientists to publish, collaborate, and contribute to advancing cancer research and clinical care worldwide.
Get involved:
📄 Submit your manuscript: [mjocs@mogitojournals.org]
✉️ Contact our editorial team: editors_mjocs@mogitojournals.org
Together, we aim to expand knowledge, improve patient outcomes, and drive innovation across every aspect of cancer science, treatment, and global care.
Join MJOCS – Call for Editors, Peer Reviewers & Oncology Research Submissions
Advance Global Cancer Research Through Open Access
The Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS) invites oncologists, cancer researchers, and healthcare professionals to join our mission of improving patient outcomes and advancing cancer science through high-quality, open-access research.
🟠 Become an Editorial Board Member
Join a network of global experts committed to scientific integrity, clinical innovation, and rigorous peer review. Editors help shape the journal’s vision, maintain academic standards, and support ethical publishing.
🟠 Serve as a Peer Reviewer
Your expertise is essential to upholding methodological rigor and research transparency. MJOCS values timely, constructive reviews that enhance the credibility and impact of oncology publications.
🟠 Submit Your Manuscript
We accept submissions across the oncology spectrum, including:
- Molecular Oncology & Cancer Genomics
- Immuno-oncology & Targeted Therapies
- Clinical & Translational Oncology
- Radiation & Surgical Oncology
- Early Detection & Diagnostic Imaging
- Epidemiology & Global Cancer Health
- Survivorship, Palliative & Supportive Care
- Pediatric, Geriatric & Rare Cancers
- AI, Imaging & Computational Oncology
Submit original research, reviews, case reports, perspectives, or commentaries. Multilingual submissions are encouraged to reflect diverse global perspectives.
🌍 Why Collaborate with MJOCS?
- Global editorial collaboration and oncology expertise
- Open access publishing for maximum visibility and impact
- Commitment to ethical research and publication transparency
- Inclusive opportunities for researchers worldwide
📩 Contact Us Today
Express interest or submit your manuscript:
📧 editors_mjocs@mogitojournals.org
📥 Submit your work: mjocs@mogitojournals.org
To celebrate the launch of MJOCS, the first 10 accepted manuscripts will be published free of charge.
Submit now and enjoy open access publishing at no cost.
👉 editors_mjocs@mogitojournals.org
Ready to Publish Your Research
We’re here to guide you through every step of your publishing journey—from submission to global reach..
Let’s advance knowledge and discovery—together.
When connected with us, you aren’t growing your business alone. We have your back and put in our best to contribute to the growth of your entire team and organization. So, if you are “When you publish with us, you’re not navigating the process alone. Our editorial team is committed to supporting you through peer review, publication, and global dissemination. If you’re looking for the right platform to share your research, enhance visibility, and make a meaningful impact—Mogito is here for you.”